Compass Therapeutics, Inc. (CMPX) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CMPX Revenue Growth
CMPX Revenue Analysis (2018–2025)
As of May 8, 2026, Compass Therapeutics, Inc. (CMPX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, CMPX's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $850,000 in 2024.
When compared to Healthcare sector peers including RCUS (+67.4% YoY), AGEN (+10.4% YoY), and TGTX (+81.3% YoY). Compare CMPX vs RCUS →
CMPX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CMPXCurrent | $0 | - | - | - | |
 RCUS | $247M | +67.4% | +25.9% | -156.3% | |
 AGEN | $114M | +10.4% | +5.3% | -18.0% | |
 TGTX | $616M | +81.3% | +426.7% | 20.0% |
CMPX Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | -100.0% | $-1,472,000 | - | $-72,839,000 | - |
| 2024 | $850K | - | $850K | 100.0% | $-56,625,000 | -6661.8% |
| 2023 | $0 | - | $0 | - | $-50,363,000 | - |
| 2022 | $0 | - | $0 | - | $-41,655,000 | - |
| 2021 | $0 | - | $0 | - | $-81,882,000 | - |
| 2020 | $0 | - | $0 | - | $-27,812,000 | - |
| 2019 | $0 | - | $0 | - | $-34,052,000 | - |
| 2018 | $0 | - | $-1,921,000 | - | $-38,312,000 | - |
See CMPX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CMPX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CMPX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCMPX — Frequently Asked Questions
Quick answers to the most common questions about buying CMPX stock.
Is CMPX's revenue growth accelerating or slowing?
CMPX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is CMPX's long-term revenue growth rate?
Compass Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is CMPX's revenue distributed by segment?
CMPX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.